DEF 14A

Company

KIORA PHARMACEUTICALS INC

Filed

April 30, 2025

Period of Report

April 16, 2025

Accession Number

0001372514-25-000038

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →